From The DT City desk.
I think that M&A is a strategy to be used sparingly.
I believe if you really focus the transaction on just the things you really care about you can create tremendous value in that space and not distract the rest of the organisation from its organic mission.
GlaxoSmithKline boss Sir Andrew Witty questioned the value of "traditional mega mergers" in the pharmaceuticals sector after the company unveiled a major transaction with its Swiss rival Novartis.
|
|
Is a fine pale ale brewed in New Zealand :)
|
Mergers are great, and an excellent approach, if done when appropriate and executed properly.
However, that "if done when appropriate and executed properly" is a killer, because they're usually not.
|
Mumbo Jumbo ? - Maisie's Dad
